Important to put COVID - cardiac apocalypse papers in context.
Reports of Sars-COV2 and & cardiac proclivity have proliferated since early 2020.
Here is @JAMACardio saying that "78% of sur-
vivors had lingering heart disease, of which 60% had myocarditis"
Here's a frequently cited preprint studying health care workers that suggested rates of myocarditis, myopericarditis, and pericarditis at 26%, 11%, and 4% respectively long after sars-cov2 recovery.
But these studies relied heavily on abnormal cardiac MRIs only to make the diagnosis of myocarditis. The healthcare worker study only had 1 patient that leaked cardiac enzymes, & half had NO symptoms. Prior to 2020 you needed clinical criteria AND abnormal imaging.
The gold standard for a diagnosis of myocarditis is a cardiac biopsy demonstrating myocardial cell necrosis with adjacent inflammatory infiltrates. Cardiac MRI may be used as a surrogate, IF the clinical finding are supportive.
A review of all Sars-COV2 autopsy studies to date provides one way of validating the high prevalence reported by the MRI studies.
In the sickest of sick patients, the number isn't close to 60%.. Myocarditis was only reported in 7.2% of cases. And even this is likely an overcount.
"There were 20 reports of myocarditis in this cohort. However, the evidence supporting 16 of these are questionable. If those cases were reported as nonspecific inflammatory infiltrates, the in-
cidence of myocarditis falls to 1.4%."
"Even among these remaining 4, it is not clear from the manuscripts that COVID-19 myocarditis was determined as the cause of death"
"The SARS pandemic (>8,000 infected) caused no known myocarditis & the MERS epidemic (>2,000) caused only a single MRI-diagnosed case of myocarditis "
" It will be incumbent on our colleagues in radiology to better interpret the meaning of cardiac MRI changes and other study data in light of this low incidence of histopathologic myocarditis "
There may be other mechanisms for cardiac injury mediated by Sars-COV2, but this would involve an indirect mechanism that, so far, has not been seen in any significant rate related to any other viruses.
I think it frankly irresponsible for doctors to leap to assume some never-before-described novel mechanism of action which will result in some tsunami of future cardiac cases.. based on MRI studies and data mining expeditions using claims data to diagnose myocarditis
Just to provide a contrast to a mrna vaccine myocarditis report..
• • •
Missing some Tweet in this thread? You can try to
force a refresh
How big of a problem is acute COVID myocarditis for children?
Pediatric cardiologist Dr. Matthew Oster, in his presentation to VRBPAC : “we had no cases to include in our analysis .. “
The majority of cases of myocarditis in children are based on its association with MIS-C .. but MIS-C myocarditis has almost no cardiac enzyme leak , and is not associated with any persistent cardiac changes on MRI in follow up.
Again compare this to vaccine myocarditis … where kids present with chest pain, have a higher troponin leak, and a third of these previously healthy kids have abnormal MRIs 3 months after..
Next, expert notes Covid mortality in the young is 1/1000. He’s corrected by a sharp @joshzepps that the # is actually 1/10000 (500/5mil) & that 5 mil is prob an undercount.
So @joshzepps facts check his expert live to combat misinformation from expert 😂 2/
When @joshzepps brings up recent study in Nature from Oxford that shows higher rates of myocarditis with vaxx than COVID in young men specifically, Expert discounts this..saying Israeli data is better. He’s referring to this paper by Barda et al. In Sep 2021 which does show ⬆️ 3/
This is the myocarditis study that was brought up by journalist @joshzepps who 'debunked' @joerogan tinyurl.com/2httdr9n
Only problem: paper made the diagnosis based on certain diagnostic codes that were charted. ICD10 codes listed include R01.1 (cardiac murmur unspecified)
Studies that are more rigorous about how myocarditis was defined (requiring lab abnormalities + imaging abnormalities + clinical symptoms) show vaxx myocarditis rates >> COVID myocarditis rates
There is a CDC report floating around that claims a 16x higher rate of myocarditis (this was mentioned by @drsanjaygupta on @joerogan ) . There are some basic major issues with this as well that I go into on this thread
A quick word about Antibody Dependent Enhancement (ADE). Must say, there is nothing to suggest this is operative at present with Sars-COV2 or the vaccines for it, but the historical context is very interesting!
ADE occurs when the antibodies generated during an immune response recognize and bind to a pathogen, but instead of preventing infection, the complex allows easier access of the pathogen into the cell.
When vaccinated individuals fall ill this is but one possibility..
The other possibilities are : 1. A mild illness (evidence the vaccine worked to prevent more severe disease 2. A breakthrough (a term normally used to describe severe illness that results even after a vaccine, which cld mean the vaxx didnt work, didnt generate enough antibodies)
Its possible for the following 2 things to be true :
1. Vaccines appear to be safe for most people, and appear to be effective in reducing the burden of severe disease
2. mRNA vaccines are associated with myocarditis (the CDC agrees : tinyurl.com/kfj9kc9y)
Much of the debate from mostly non-cardiologists focuses on "mildness" of vaxx-myocarditis, and risk of myocarditis from Sars-COV2 (COVID).
Some thoughts :
1st - multiple datasets beyond the much maligned VAERS report links vaccines with
myocarditis
Israeli Study: Notice uptick after 2nd shot.
"Most cases were mild or moderate in severity, but one patient had cardiogenic shock, and one patient with preexisting cardiac disease died of an unknown cause soon after hospital discharge." tinyurl.com/hd3nrbun
@Jabaluck acknowledges the concern about effective randomization because the survey teams that enrolled participants were more motivated to enroll patients in villages randomized to masks. [~14,000 more Pts were in the mask intervention than control.]
This imbalance creates a potential fundamental problem because the 1º endpoint (symptomatic sero positive patients) only differed by a total of 20 cases in the 10,000 out of 300,000 patients that were convinced to give blood samples.